Tirzepatide cost without insurance depends on the route. Brand-name tirzepatide for weight management lists at $499 to $1,086.37 per fill, and the manufacturer’s self-pay price is $299 to $699, depending on the prescribed dose. InjectCo’s supervised compounded tirzepatide program is $425 a month or $1,800 for a 6 to 8 month program.
Written by Kiara DeWitt, BSN, RN, CPN, Founder and CEO of InjectCo
Medically reviewed by Dr. Josh Allen, D.O., Medical Director, October 23, 2026
Disclaimer: This article is general education, not medical or financial advice, and results vary. Manufacturer prices were checked on 24 October 2026 and can change, so confirm them before you buy.
If price is the reason you have not started, you are not alone. Many people look up tirzepatide, see a four-figure number and assume treatment is out of reach. That number is only one of several prices, and it is rarely the one a cash-paying patient pays.
The list price, also called the wholesale acquisition cost (WAC), is what the manufacturer charges wholesalers. It is not the price at the pharmacy counter. Your pharmacy sets its own retail price, and insurance or savings programs change your share.
According to the manufacturer’s pricing page (WAC as of 1 January 2026, checked 24 October 2026), brand-name tirzepatide for chronic weight management lists at $499 to $1,086.37 per fill. One fill is a 28-day supply. The brand-name tirzepatide product for type 2 diabetes has its own list price of $1,112.16 per fill.
The manufacturer also sells the weight management product directly to people paying cash, at $299 to $699 per fill depending on the prescribed dose, in vials or a pen. This direct price is not the WAC, and it is only for cash-paying patients. You still need a prescription from a licensed provider.
A lower number does not always mean a lower total cost. Ask what is included, who is monitoring you, where the medication comes from, and what support you get if side effects or a plateau show up.
| Route | What you pay | What to know |
|---|---|---|
| List price at a retail pharmacy | $499 to $1,086.37 per fill (WAC, 1 January 2026) | Your pharmacy’s price can differ from list |
| Manufacturer self-pay | $299 to $699 per fill, depending on the prescribed dose | Cash pay only; prescription required; manufacturer terms apply |
| Manufacturer savings card | As low as $25 for a one- or three-month supply of pens | Only with commercial insurance that covers the drug; government beneficiaries excluded; limits apply |
| HSA or FSA money | Pre-tax dollars, not a discount | May qualify with a diagnosis; your plan decides |
| InjectCo supervised compounded program | $425 a month or $1,800 for a 6 to 8 month program | Consult, labs, medication when prescribed, check-ins every 2 weeks |
When you pay out of pocket, compare the whole cost, not just the first monthly number. A medication-only price leaves the prescriber visit, labs and follow-up to be paid somewhere else. Some programs also add separate charges for visits, supplies or follow-ups.
Two people paying out of pocket can get very different quotes. The main reasons:
Brand-name tirzepatide comes from the manufacturer that ran the clinical trials, and it is FDA-approved for the uses on its label. When you pay without insurance, more of its price lands on you.
Compounded tirzepatide is prepared by a pharmacy for an individual patient’s prescription. Compounded drugs are not FDA-approved, which means FDA does not review them for safety, effectiveness or quality before they are marketed. FDA’s compounding questions and answers say the same: FDA does not verify their safety, effectiveness or quality. Compounded programs are often priced as a monthly package that includes care, so line up what each price covers before you compare.
| Factor | Brand-name tirzepatide | Compounded tirzepatide |
|---|---|---|
| FDA status | FDA-approved for its labeled uses | Not FDA-approved |
| Who makes it | The manufacturer | A compounding pharmacy, for an individual prescription |
| Insurance coverage | Sometimes, depending on your plan and diagnosis | Usually paid out of pocket |
| How it is priced | Medication priced separately from provider visits | Often bundled with evaluation and follow-up in a program |
A lower price is not a reason to skip medical oversight. Either way, tirzepatide needs a prescription from a licensed provider, and someone should be watching your progress and side effects while you take it.
Talk with an InjectCo provider about whether a supervised tirzepatide plan fits your health history and goals.
$425 a month or $1,800 for a 6 to 8 month program
InjectCo’s tirzepatide weight loss program is $425 a month or $1,800 for a 6 to 8 month program. The price covers:
You can come in person or use telehealth, and you can pay yourself or with an HSA or FSA card. A licensed prescriber working under Dr. Josh Allen, D.O., Medical Director, reviews your health history before anything is prescribed. Compounded medications are not FDA-approved, and results vary. Tirzepatide can cause side effects, so tell your provider about any concerns while you are on the program.
If you would rather spread the cost, read about paying over time.
Often, yes. IRS Publication 502 counts prescribed drugs and weight-loss treatment for a disease diagnosed by a physician, so tirzepatide prescribed for a diagnosed condition such as obesity may qualify. Your plan administrator decides each claim, and it may ask for an itemized receipt, the prescription or a Letter of Medical Necessity.
Tirzepatide is not right for everyone, and a licensed provider has to evaluate you before it is prescribed. At InjectCo, your nurse reviews your medical history, current health and medications first.
Based on the FDA label for tirzepatide for chronic weight management, you may be a candidate if:
The label says it should not be used if you or a family member has had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have had a serious allergic reaction to tirzepatide. It should be stopped if you become pregnant. If you are breastfeeding, talk with your provider first.
To set realistic expectations, read how much weight you can lose on tirzepatide, or compare semaglutide cost without insurance.
The manufacturer lists brand-name tirzepatide for weight management at $499 to $1,086.37 per fill (WAC as of 1 January 2026), and sells it to cash-paying patients for $299 to $699 per fill, depending on the prescribed dose. InjectCo’s supervised compounded tirzepatide program is $425 a month or $1,800 for a 6 to 8 month program, including a consult, labs and regular check-ins.
Compare the manufacturer’s self-pay price, a supervised compounded program, and your HSA or FSA if your plan allows it. Then look at what each monthly price includes, such as the provider visit, labs, supplies and follow-up care. A medication-only price can look smaller until you add the care you still need, so compare the total cost and not just the first number.
It depends on the route. The manufacturer’s self-pay price for its weight management product changes with the prescribed dose, from $299 to $699 per fill. Some compounded programs charge one monthly rate, while others charge more at higher doses. InjectCo’s program is $425 a month or $1,800 for a 6 to 8 month program, and your nurse can walk you through your plan at your consultation.
Only in limited cases. The manufacturer’s savings card can bring the cost as low as $25 for a one- or three-month supply of pens, but only if you have commercial insurance that covers the drug. Government beneficiaries are excluded, savings have monthly and annual limits, and the terms can change. It does not apply if you are paying without insurance.
Coverage depends on your plan and your diagnosis. Some commercial plans cover brand-name tirzepatide when it is prescribed for type 2 diabetes, while coverage for weight management is less consistent, so many people end up paying out of pocket. Compounded tirzepatide is usually not covered by insurance, though HSA or FSA money may be usable when it is prescribed for a diagnosed condition.
No. Compounded tirzepatide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. A licensed provider can prescribe it, and a licensed compounding pharmacy can prepare it for an individual patient. At InjectCo, a licensed prescriber reviews your history before anything is prescribed, and your program includes regular check-ins.
If you have been comparing tirzepatide prices online, it makes sense to compare prices. It is just as important to know what each price includes.
With InjectCo, you are not only paying for medication. Your $425 a month or $1,800 for a 6 to 8 month program includes a consult, labs, medication when prescribed, check-ins every 2 weeks and a monthly dose review, in person or by telehealth, with support if your body responds differently than expected.
A licensed provider reviews your medical history before anything is prescribed.
$425 a month or $1,800 for a 6 to 8 month program
days day
hours hour
minutes minute
seconds second
